Navigation Links
Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT
Date:9/23/2008

ore you take your medicine.

For full prescribing information, please visit http://www.spiriva.com.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and approximately 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2007, Boehringer Ingelheim posted net sales of US $15.0 billion (10.9 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit http://us.boehringer-ingelheim.com.

Pfizer Inc: Working together for a healthier world(TM)

Founded in 1849, Pfizer is the world's largest research-based pharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support. At Pfizer, more than 80,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide.

Referen
'/>"/>

SOURCE Boehringer Ingelheim; Pfizer Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
2. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
3. 338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment
4. Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
5. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
6. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
7. FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
8. Secretary Reinforces VAs Commitment to Research Safety and Veteran Focus
9. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
10. Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... MOUNTAIN VIEW, Calif. , May 28, 2015 ... healthcare informatics market, Frost & Sullivan recognizes ... Frost & Sullivan Award for Company of the ... effort to take HCM to the next level ... highly strategic acquisitions and followed them up with ...
(Date:5/28/2015)... -- Cardinal Health today announced that its March 1, 2015 ... for $1.944 billion in cash was formally accepted.  The ... and trade unions. The transaction is expected to close ... key non-U.S. countries towards the end of 2015, subject ... Headquartered in Fremont, Calif. , ...
(Date:5/28/2015)... SAN DIEGO , May 28, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, announced today the launch ... Campaign for its Precision Cancer Monitoring SM ... Oncology Annual Meeting. The campaign will center on ... can gain hands on clinical experience with the ...
Breaking Medicine Technology:Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5Cardinal Health Binding Offer To Acquire Cordis Accepted 2Cardinal Health Binding Offer To Acquire Cordis Accepted 3Cardinal Health Binding Offer To Acquire Cordis Accepted 4Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 2Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 3Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 4
... Boston Scientific Corporation (NYSE: BSX ) ... quality of life outcomes, based on one-year data from ... while the overall cost effectiveness of percutaneous coronary intervention ... according to patient characteristics, PCI was more cost effective ...
... to be presented at Israel Society of ... reach 5 months from single treatment - Data ... scores of expensive injections MISGAV, Israel and LONDON, March ... that the latest, encouraging results of the Company,s ongoing ...
Cached Medicine Technology:SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 2SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 3SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 4SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 5Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients 2Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients 3Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients 4
(Date:5/28/2015)... (PRWEB) May 28, 2015 The Khanna ... interactive keratoconus web application to make learning about ... in the last few years. This proliferation of treatment ... are not aware of the nuances of the cutting ... Institute, realized that websites can be boring and printed ...
(Date:5/28/2015)... May 28, 2015 Sexual Health ... that advances sexual health and wellbeing in the ... of San Francisco (USF) will be the first ... assault recording and reporting system. , Callisto ... and confidential reporting experience for college sexual assault ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Optimity ... and implementing innovative models of care for healthcare ... support alternative reimbursements and help operationalize contracting and ... also unveils a bi-weekly series of seven “ ... Outcomes Based Contracting. Optimity is a strategy, operations ...
(Date:5/28/2015)... Cancer survivors who participated in the ... activity, fitness and quality of life, according to research ... and Jennifer Ligibel, MD, senior physician in the Susan ... Institute. The findings will be presented at this year’s ... Meeting in Chicago. , The study, designed ...
(Date:5/28/2015)... 28, 2015 The drug epidemic has struck ... article published on May 12th, 2015, by Bradenton , ... of time. The first victim, Dylan Besser (21) was a ... the scene. The second overdose victim, Julian Toomsen-Hall (18) was ... the alarming overdose deaths on campus, the college has created ...
Breaking Medicine News(10 mins):Health News:Dr.Khanna Announced the Release of an Interactive Web Application for Keratoconus Treatment 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 3
... national study of escalator-related injuries to older adults, researchers ... Dr.PH., MPH, of the Indiana University School of Medicine, ... from 1991 to 2005. The results of the study ... journal Accident Analysis and Prevention. , Using U.S. Consumer ...
... FALL RIVER, Mass., March 13 Millstone ... signed agreements,with four companies to provide loaner ... facility, which opened in October 2007.,Two of ... Innovative Spinal Technologies, Inc. and OMNI life ...
... to Ease the Process for Physicians to Select Electronic ... Ohio State,Medical Association (OSMA) announced that it is launching ... its kind, to help reduce the risk for,physicians who ... for,their practices., The Standards of Excellence Program, which ...
... on Restorative Options, HARRISBURG, Pa., March 13 ... PDA member dentists use a recently,published brochure by ... with patients., "The Pennsylvania Dental Association encourages ... oral health issues," said Dr. Jon J.,Johnston, President ...
... study at the University of Texas Medical Branch at ... most common diseases of young children: colds and ear ... 15 issue of Clinical Infectious Disease, confirmed the suspected ... young children, viral colds and ear infections. It also ...
... Mich. A commonly used medication that prevents blood ... damaging delicate vein walls and may accelerate healing ... new research from the University of Michigan Cardiovascular Center. ... more evidence to support the aggressive anti-clot efforts now ...
Cached Medicine News:Health News:Rate of escalator injuries to older adults has doubled 2Health News:Customers Take Advantage of Loaner Kit Processing Services at Millstone Medical Outsourcing's Memphis Facility 2Health News:Customers Take Advantage of Loaner Kit Processing Services at Millstone Medical Outsourcing's Memphis Facility 3Health News:OSMA Launches EMR Standards of Excellence Program 2Health News:OSMA Launches EMR Standards of Excellence Program 3Health News:OSMA Launches EMR Standards of Excellence Program 4Health News:OSMA Launches EMR Standards of Excellence Program 5Health News:Pennsylvania Dental Association Urges Members to Use New ADA Educational Material 2Health News:Researchers confirm link between common cold and ear infection 2Health News:Damaged veins heal faster with heparin treatment, laboratory study finds 2Health News:Damaged veins heal faster with heparin treatment, laboratory study finds 3Health News:Damaged veins heal faster with heparin treatment, laboratory study finds 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: